BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $292,450 | -70.8% | 6,419 | -65.4% | 0.01% | -76.3% |
| Q3 2022 | $1,000,000 | -26.6% | 18,573 | -12.5% | 0.06% | -7.8% |
| Q2 2022 | $1,363,000 | -17.0% | 21,226 | +0.2% | 0.06% | -3.0% |
| Q1 2022 | $1,643,000 | +13.5% | 21,187 | +25.7% | 0.07% | +26.9% |
| Q4 2021 | $1,447,000 | -9.0% | 16,854 | -14.7% | 0.05% | +4.0% |
| Q3 2021 | $1,590,000 | +20.9% | 19,768 | +21.0% | 0.05% | +61.3% |
| Q2 2021 | $1,315,000 | +26.8% | 16,341 | +32.9% | 0.03% | +24.0% |
| Q1 2021 | $1,037,000 | -11.3% | 12,300 | -15.6% | 0.02% | 0.0% |
| Q4 2020 | $1,169,000 | -17.0% | 14,572 | -16.8% | 0.02% | -19.4% |
| Q3 2020 | $1,408,000 | -17.9% | 17,505 | -12.2% | 0.03% | -18.4% |
| Q2 2020 | $1,716,000 | +23.6% | 19,936 | +16.6% | 0.04% | +15.2% |
| Q1 2020 | $1,388,000 | +12.5% | 17,097 | +15.8% | 0.03% | +17.9% |
| Q4 2019 | $1,234,000 | -30.0% | 14,760 | -26.7% | 0.03% | -30.0% |
| Q3 2019 | $1,762,000 | +215.2% | 20,148 | +195.1% | 0.04% | +207.7% |
| Q2 2019 | $559,000 | +0.7% | 6,828 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $555,000 | -2.3% | 6,828 | -20.9% | 0.01% | -7.1% |
| Q4 2018 | $568,000 | -48.8% | 8,628 | -40.1% | 0.01% | -41.7% |
| Q3 2018 | $1,110,000 | -41.0% | 14,393 | -43.5% | 0.02% | -45.5% |
| Q2 2018 | $1,881,000 | +646.4% | 25,477 | +557.3% | 0.04% | +633.3% |
| Q1 2018 | $252,000 | -94.7% | 3,876 | -94.8% | 0.01% | -94.5% |
| Q4 2017 | $4,783,000 | -2.3% | 73,992 | -5.2% | 0.11% | -1.8% |
| Q3 2017 | $4,898,000 | +85.5% | 78,055 | +78.9% | 0.11% | +88.1% |
| Q2 2017 | $2,641,000 | +843.2% | 43,621 | +1040.1% | 0.06% | +1080.0% |
| Q4 2014 | $280,000 | -35.6% | 3,826 | -36.9% | 0.01% | -37.5% |
| Q3 2014 | $435,000 | +111.2% | 6,062 | +112.3% | 0.01% | +166.7% |
| Q2 2014 | $206,000 | -1.9% | 2,855 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $210,000 | +5.5% | 2,855 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $199,000 | +76.1% | 2,855 | +66.0% | 0.00% | +50.0% |
| Q3 2013 | $113,000 | -5.0% | 1,720 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $119,000 | – | 1,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |